Search

In an ideal, imagined world, you would not be meeting the 14 emerging leaders in healthcare we selected in these pages but in person. You could talk to Courtney Bragg, [...]

We weren't planning on having so much coverage of glucagon-like peptide 1 (GLP-1) drugs in this issue. But no matter where it starts, every conversation about managing care these days [...]

It is always a treat to review the results of Managed Healthcare Executives annual pharmacy survey and this year is no exception. CMS drug price negotiation under the Inflation Reduction [...]

Last year the Pew Research Center announced that it was tightening up how it would conduct and report on generational research. It's crucial to account for age when comparing generations, [...]

The pharmacy benefit management (PBM) industry has emerged as one of the most important, interesting and perhaps controversial sectors of American healthcare. As we discuss in this issue's cover story, [...]

Ozempic, once a drug that only diabetes specialists and perhaps people with the disease were aware of, has become a household word. Since last year, it has been all over [...]

Making predictions at the beginning of the year is really kind of a fool's errand. Sure, it is cognitively comforting to think that events are going to unfold in a [...]

Our last issue of 2023 features our annual State of Industry survey, which gives us a peek into what you, our readers, are thinking about U.S. healthcare. Of course, surveys [...]

The full gamut of what Managed Healthcare Executive covers is on display in this issue. In our standing 'Drugs in the Pipeline' feature we keep tabs on new drugs in [...]

We are devoting 10 pages of this issue to our coverage of the 2023 PBMI Annual National Conference. Managed Healthcare Executive is the official publication of the meeting, and the [...]

Year in, year out, Managed Healthcare Executive's annual emerging leaders cover story is one of our favorites. One reason is the sense of optimism that comes from getting to know [...]

Remember when Sovaldi (sofosbuvir), the new hepatitis C antiviral, came on the market in 2014? Its price of $84,000 for 12-week course of treatment seemed astronomical. But $84,000 for a [...]

Expectations were sky-high for alternative payment models. The notion of shifting the incentives in American healthcare to reward high-quality care, prevention and cost effectiveness was attractive. Alternative payment models seemed [...]

It is difficult these days to remember a time when healthcare wasn't so dependent on the computer and digital storage and exchange of information. Sure, there are some relics to [...]

Covering medical meetings and conferences is the lifeblood of MJH Life Sciences[R]. Especially during the spring and fall months, our editors fan out across the U.S., sometimes beyond, to cover [...]

'Disruption' gets bandied about a lot, especially in U.S. healthcare. Clayton Christensen, a Harvard Business School professor, is credited with developing the theory of disruption innovation, and his 1997 book, [...]

The fundamental purpose of most types of insurance is to protect businesses and people from the dire financial consequences of rare and expensive events. Car insurance doesn't pay for oil [...]

Our annual State of the Industry survey is always a good way to begin the year. The results give us some fresh insight into what is on the minds of [...]

Pharmacy benefit managers (PBMs) used to reside in a fairly obscure, relatively quiet nook among the many nooks and crannies of accretive U.S. healthcare. They paid claims. They helped trim [...]

We are in an era of unprecedented innovation and promise when it comes to drugs to treat disease. Research has revealed the Achilles' heel of an increasing number of diseases [...]

In early 2020, MJH Life Sciences[R] acquired the Pharmacy Benefit Management Institute[R] (PBMI) and its Annual National Conference. That's only a little more than two years ago, but the massive [...]

Our list of emerging industry leaders is one of our favorite features of the year, perhaps the favorite. The variety of experiences, the accomplishments, the sense of promise--it's all profoundly [...]

COVID-19 pandemic and drug prices continue to dominate healthcare news in the United States, and our annual pharmacy survey revealed the complicated, and sometimes surprising, attitudes about them. More than [...]

So many issues and beliefs divide Americans these days that it is surprising to come upon any areas of agreement. But as Robert Calandra reports in this issue's cover story, [...]

The growth in enrollment in Medicare Advantage (MA) plans has been attracting a lot of attention lately. Close to half of Medicare beneficiaries have opted for an MA plan, and [...]

Social determinants of health (SDOH) are a trending topic in U.S. healthcare. But as Timothy Kelley discusses in the cover story of this issue of Managed Healthcare Executive', the idea [...]

We are now two years into the COVID-19 pandemic. In early 2020, few of us foresaw just how significant this novel respiratory disease would be. Experts were caught off guard. [...]

In this issue of Managed Healthcare Executive', we have an example of something that is new in healthcare--and also something that is tried-and-true, a throwback to an earlier era. The [...]

The app is a great innovation. Almost every need can be met by one, every curiosity satisfied. Nobody likes to pay for parking, but if you have to, the parking [...]

In a trivia contest, most of us could probably answer a few questions about DNA. That it has that iconic double-helix shape, discovered by Watson and Crick (bonus points if [...]

Our emerging health leaders cover story has become a high point in our editorial calendar. This year we increased the roster of up-and-comers to a baker's dozen. It just became [...]

Medicare Advantage (MA) has been one of the success stories in American healthcare over the past 20 years. Enrollment has grown steadily since the early 2000s, so now about 42% [...]

Early on, whispers of a potentially engineered virus out of China were so pervasive that, in February 2020, a group of 27 public health scientists published a letter in The [...]

Last year the results from our annual pharmacy survey were published a month later, in the July issue. Midsummer 2020 was a difficult period in the history of the pandemic [...]

Throughout the COVID-19 pandemic, the American economy, and especially the healthcare sector, have been remarkably resilient and innovative. When all of the activities and services that we assumed needed to [...]

The advances in medical technology have saved untold lives and prevented incalculable suffering. The fact that we now have three vaccines against COVID-19 in the United States testifies to the [...]

As we were putting this issue of Managed Healthcare Executive' to bed, the country passed what many headlines called a grim milestone. The death toll in the U.S. from the [...]

In many respects, the results of our reader survey about the healthcare challenges in 2021 are not all that surprising. We are still very much in this pandemic and COVID-19 [...]

Technology can be a disruptive force in healthcare, upending tried-and-true ways of doing things. Look at how laparoscopic techniques changed many forms of surgery and how MRI scans fundamentally altered [...]

Our annual State of the Industry reader survey is a peek into the window of what Managed Healthcare Executive' readers are thinking about and dealing with. We fully appreciate the [...]

We often find eloquence in dire circumstances, limning dark topics and fearsome subjects. Siddhartha Mukherjee's Pulitzer Prize-winning The Emperor of All Maladies is such a place. Explanations that in other [...]

Parents aren't supposed to have favorites among their children, but it is perfectly OK for publications to have favorites among their features. And '10 Emerging Industry Leaders' is definitely one [...]

COVID-19 has not been an equal opportunity pandemic. It is a now-familiar fact that the disease has had a disproportionate effect on older people and Black Americans. And, as we [...]

When we started working on this issue of Managed Healthcare Executive' we thought we would be telling you about American healthcare rebounding from COVID-19. The 'new normal' has quickly become [...]

'Just when I thought I was out, they pull me back in!' says an older Michael Corleone in The Godfather, part three. It's a famous line and GIF. COVID-19 is [...]

Just as we were emerging from the COVID-19 outbreak and businesses were beginning to open up to a 'new normal,' a second crisis hit the country because of the killing [...]

Over a million cases in the United States. About 60,000 deaths. The economy and much of life on hold. The COVID-19 outbreak was still very much with us as I [...]

Even though it is only April, it's a safe--no, a certain--bet that the COVID-19 outbreak will be the biggest healthcare story of 2020. Going into this year, we had ideas [...]

This month's issue of Managed Healthcare Executive[R] features a review of conditions that will tax the U.S. health system over the next decade. There are no surprises here: The related [...]

Today, the way people decide what to buy, where to eat, and where to travel is often driven by reviews--either accounts that appear in print or online, or perhaps firsthand [...]